Bioanalytical insights into mediator lipidomics.

Area of Science:

• Biochemistry
• Analytical Chemistry
• Molecular Biology

Background:

• Lipids are vital in health and disease, undergoing conversions to potent lipid mediators (LMs).
• LMs regulate cellular signaling, inflammation, and various biological events, often via G-protein-coupled receptors (GPCRs).
• Monitoring LMs is key to understanding pathogenesis in diseases like asthma, arthritis, Alzheimer's, and cancer.

Purpose of the Study:

• To review recent advancements in human mediator lipidomics.
• To highlight bioanalytical insights for effective sample preparation and matrix effect evaluation.
• To discuss the importance of sensitive, accurate, and robust analytical methods for LM quantification.

Main Methods:

• Utilizing advancements in mass spectrometry for highly sensitive and multiplexed LM analyses.
• Employing temporal and spatial profiling of LMs in human periphery and tissues.
• Focusing on polyunsaturated fatty acids (PUFAs) and their derived LMs (e.g., eicosanoids, lipoxins, resolvins).

Main Results:

• Sensitive and multiplexed analyses of LMs are now feasible in human samples.
• LM profiling offers potential for decoding complex disease pathologies.
• Challenges in mediator lipidomics validation, including matrix effects and extraction efficiency, require careful consideration.

Conclusions:

• Mediator lipidomics is a rapidly advancing field with significant potential for biomedical research.
• Accurate quantification of LMs necessitates robust analytical methods and careful validation.
• Understanding LM profiles can illuminate disease mechanisms and potentially guide therapeutic strategies.